Jason Raeburn

Jason’s experience prior to joining Latham includes representing:

IP Litigation — Technology

• A multinational technology innovation company in its US$12 billion nanotechnology dispute in confidential arbitration proceedings involving breach of contract, trade secret, and patent entitlement issues
• A leading AI developer in its:
  • US$180 million arbitration under ICC Rules in relation to complex interpretation issues arising from related trade secrets lawsuits in the US District Court for the District of Columbia
  • English law-governed allegations of breach of confidence/trade secret misappropriation by an ex-director and rival company
• A multinational platform provider in its defense of a US$32 million arbitration under LCIA Rules relating to allegations of breach of confidence, material breach of contract, and purported failures to adhere to obligations of good faith in relation to a collaboration agreement for the provision of platform software and associated services to third parties
• A multinational information and communications technology equipment and services company in the settlement of its global FRAND/SEP confidential dispute with streaming technologies licensors, including approach to the defense of Unified Patent Court (UPC), UK, Brazilian, and US proceedings
• A leading consumer technology company in its UK and European litigation strategy in connection with significant FRAND patent licensing disputes relating to transmission technologies, including Wi-Fi, semiconductors, optical networks, and electronic devices
• An industrial manufacturer in its global patent and trade secrets litigation strategy in connection with fractionation technologies, including strategy for UPC, UK, and international actions
• An international music publishing company and related artists in a US$300 million copyright infringement dispute with investors over bond issuances relating to music catalogues, involving allegations across the US and UK and associated conflict of laws issues

IP Litigation — Life Sciences

• A leading life sciences company in its US$2 billion international arbitration under ICC Rules involving the interpretation of a license and collaboration agreement relating to an innovative drug product, resulting in the award of more than US$22 million in fees and costs
• A large European-headquartered pharmaceutical company in its defense of a US$288 million arbitration under ICC Rules relating to the interpretation, validity, and operation of complex pricing terms for the manufacture, sale, and export of pharmaceutical products for anti-inflammatory, anti-asthmatic, and antibiotic medications
• A biopharmaceutical company in its patent protection and litigation strategy in Europe in connection with clinical drug candidates for a range of treatments
• A multinational life sciences company in overlapping UPC, US, European Patent Office (EPO), and international court litigation around the globe to overcome patent ownership issues for a market-leading hormone treatment therapy, valued in the billions
• A leading innovating life sciences company in connection with its patent and contract arbitration regarding complex processes to purify linearized DNA, involving entitlement and royalty issues arising from portfolios of over 200 patents relating to scientific manufacturing processes
• A multinational life sciences company in its “hybrid” contractual and intellectual property/trade secrets arbitration relating to the allocation and ownership of inventions under a collaboration to develop and commercialize polypeptide-based bispecific antibodies used in combination with proprietary technologies to treat a group of uncontrolled cell growth diseases

Commercial Litigation

• Securities investors in connection with the €11.8 billion bond issuance litigation as part of Palladian Partners v. Republic of Argentina in the English High Court and the Court of Appeal
• A multinational media conglomerate in the successful defense of US$900 million in damages asserted against it in connection with the alleged breach of multiple global contracts and joint venture agreements
• Ripple in Ripple v. Taasai and Ripple v. GCC in cross-border litigation in the Commercial Court of the High Court of England and Wales relating to crypto token issuances
• One of Europe’s largest infrastructure companies in its US$3 billion data center dispute in relation to hosting services across France, the UK, and Ireland
• The beneficiaries of a US$860 million trust relating to international film rights in connection with parallel disputes in the English courts and US state courts for negligent investment advice, breach of trust, and breach of fiduciary duty
• A large multinational in defending a number of mass arbitrations concerning more than 200,000 claimants and over US$280 million in damages sought relating to the purported breach of consumer agreements, including issues of interpretation relating to conflict of laws

Artificial Intelligence

• One of the largest AI organizations in the world in connection with strategic responses to copyright litigation on generative AI development and implementation
• A multinational AI company on issues relevant to the expansion of generative AI across the EU in connection with voice technology for natural speech synthesis
• One of the largest global technology providers on litigation, regulatory, and transparency requirements relating to the launch of new generative AI video creation technology
• A multinational technology company in its strategy for implementation of the EU AI Act, including its approach to open-source software and open-source training models
• A leading machine learning company in copyright and open-source software issues relating to the release of transformer-based language models for code generation and filtering
• One of the largest brokers in the world in developing its computer vision algorithms and AI models, including copyright and open-source analyses for image corpuses
• A generative AI organization in connection with a UK public inquiry into internet usage on the operation and effectiveness of AI models for anti-CSAM techniques (the use of image re-hashing and search technology, assisted by machine learning to improve accuracy in identifying images x-platform)
• A leading software provider in litigation asserting trade secret, copyright, and database rights against a publicly listed insurance company relating to the use and exploitation of AI engines used as part of complex modelling operations for financial services
• A multinational technology company in legal issues arising from the development and deployment of intelligent document processing models using natural language processing and object detection engines
• A multinational technology company in litigation issues arising from the development and protection of AI algorithms used in neuroimaging analysis
• An international consumer technology company in its litigation strategy with respect to its generative AI technologies and operations in connection with training and developing models
• A leading online platform in intellectual property and regulatory implications relevant to the launch of a generative video and music product in 19 jurisdictions globally
• A renowned multinational computer technology corporation in its development of native AI solutions, including issues arising from using third-party AI models and research and development activities
• A multinational technology company in the legal issues surrounding the inception, development, and engineering changes necessary to incorporate new features for AI and analytics navigating the UK, European, and US (federal and state) laws relating to novel AI regulation and privacy issues

Data

• Multinational companies, including across the EU, US, and Asia, in strategy and managing international litigation arising from cyber breaches
• Companies in regulatory appeals in connection with data processing agreement (DPA) enforcement
• LastPass in advocacy before the UK ICO in connection with its penalty notice in respect of purported infringes of UK GDPR relating to encryption technologies
• A leading finance technology company in connection with civil claims arising from alleged supply chain data breaches and associated third-party claims
• A leading cloud company in connection with asserted class action data subject claims for damages arising from browser cookie circumvention and tracking technologies
• A multinational investment and financial services company asserting over US$700 million in damages for contractual breaches relating to the misuse of data against a publicly listed insurance company as part of complex platform arrangements
• A multinational technology platform in claims from consumers and business users arising from alleged GDPR breaches in connection with the facilitation of targeted advertising
• One of the largest media companies in the world in litigation arising from the operation of its advertising exchange and associated data breaches across the EU and UK
• An online consumer goods platform in its international regulatory engagement and enforcement appeals, and related third collective action proceedings in the UK
• A multinational technology intermediary on the UK Competition Appeal Tribunal and group litigation order (GLO) claims faced in connection with an incident resulting in the exposure of substantial amounts of user data
• A leading financial institution in asserted GLO proceedings in the High Court relating to credit data disclosures and transfers